Share Name Share Symbol Market Type
Novartis Ag NYSE:NVS NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -$0.11 -0.12% $89.16 $89.36 $88.65 $89.36 1,728,506 22:37:42

Amgen, Novartis, Banner Institute Discontinue Alzheimer's Prevention Clinical Research Program

11/07/2019 10:30pm

Dow Jones News

Novartis (NYSE:NVS)
Historical Stock Chart

1 Month : From Jun 2019 to Jul 2019

Click Here for more Novartis Charts.
   By Stephen Nakrosis 

Amgen Inc. said Thursday a clinical research program it was conducting into Alzheimer's prevention with Novartis AG (NVS) and the Banner Alzheimer's Institute was being discontinued.

The program was studying the effect of the BACE1 inhibitor CNP520, or umibecestat, as part of the Alzheimer's Prevention Initiative Generation Program, Amgen said. Specifically, the program was researching the safety and efficacy of CNP520 for the prevention or delay of the onset of Alzheimer's disease in certain patients.

Amgen said "After review of clinical data, the sponsors concluded that the potential benefit for participants in the studies did not outweigh the risk."

Amgen and Novartis formed a global collaboration in 2015 to develop and commercialize pioneering treatments in the field of migraine and Alzheimer's disease. The studies are sponsored by Amgen and Novartis, in collaboration with Banner Alzheimer's Institute, Amgen said.

David Reese, executive vice president of Research and Development at Amgen, said "Although the outcomes of the research program did not lead to the results we aimed for, we are committed to sharing our findings to help advance the medical and scientific community one step further toward finding a prevention for this devastating disease."


--Write to Stephen Nakrosis at


(END) Dow Jones Newswires

July 11, 2019 17:15 ET (21:15 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

1 Year Novartis Chart

1 Year Novartis Chart

1 Month Novartis Chart

1 Month Novartis Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190716 22:17:58